IL1B and Sepsis: It was further found that prevention of necroptosis activation either by IL-1β-siRNA or RIP1 antagonist could improve the neurodevelopment deficit caused by neonatal LPS injection, suggesting that necroptosis contributed to neuronal loss or injury following neonatal sepsis.